QIMR Berghofer scientists have uncovered hundreds of genes that play a role in the growth of both moles and melanoma, in a ...
Chronic kidney disease affects more than 850 million people worldwide and continues to impose a heavy clinical and economic ...
New research to be presented today at the annual conference of the European Society of Human Genetics shows that a cancer ...
The chemicals flowing through your bloodstream tell a story that your DNA alone cannot. They reflect what you eat, how your ...
Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with ...
Opus Genetics (IRD) rated Hold: valuation hinges on AAV gene therapy success. Track LCA5 Phase 3, 2026 data catalysts & ...
While Opus Genetics, Inc. (NASDAQ:IRD) has gained 100.50% year-to-date, analysts continue to see 148.10% upside, helping it ...
Almost 50 more genes have been flagged as being linked to Alzheimer’s, along with changes in activity in crucial cells that ...
SOPHiA GENETICS (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, today confirmed, ahead of its 2026 Annual ...
View SOPHiA GENETICS SA SOPH stock quote prices, financial information, real-time forecasts, and company news from CNN.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results